PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease
| Main Authors: | , , , |
|---|---|
| Format: | Conference item |
| Published: |
2009
|
| _version_ | 1826259259976843264 |
|---|---|
| author | Bekker, P Keshav, S Johnson, D Schall, T |
| author_facet | Bekker, P Keshav, S Johnson, D Schall, T |
| author_sort | Bekker, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:47:03Z |
| format | Conference item |
| id | oxford-uuid:0ede6e1b-bdf1-4abd-8156-aade05ae0d77 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:47:03Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:0ede6e1b-bdf1-4abd-8156-aade05ae0d772022-03-26T09:48:13ZPROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's DiseaseConference itemhttp://purl.org/coar/resource_type/c_5794uuid:0ede6e1b-bdf1-4abd-8156-aade05ae0d77Symplectic Elements at Oxford2009Bekker, PKeshav, SJohnson, DSchall, T |
| spellingShingle | Bekker, P Keshav, S Johnson, D Schall, T PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease |
| title | PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease |
| title_full | PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease |
| title_fullStr | PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease |
| title_full_unstemmed | PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease |
| title_short | PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease |
| title_sort | protect 1 maintenance phase study results demonstrate efficacy of the intestine specific chemokine receptor antagonist ccx282 b traficet en in crohn s disease |
| work_keys_str_mv | AT bekkerp protect1maintenancephasestudyresultsdemonstrateefficacyoftheintestinespecificchemokinereceptorantagonistccx282btraficetenincrohnsdisease AT keshavs protect1maintenancephasestudyresultsdemonstrateefficacyoftheintestinespecificchemokinereceptorantagonistccx282btraficetenincrohnsdisease AT johnsond protect1maintenancephasestudyresultsdemonstrateefficacyoftheintestinespecificchemokinereceptorantagonistccx282btraficetenincrohnsdisease AT schallt protect1maintenancephasestudyresultsdemonstrateefficacyoftheintestinespecificchemokinereceptorantagonistccx282btraficetenincrohnsdisease |